Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Exploratory, international, multi-centre, randomized, investigator blinded study in acne
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CD0271 0.1%/CD1579 2.5% gel | Experimental | Split-face design, one application a day for 6 months |
|
| CD0271 0.1%/CD1579 2.5% gel vehicle | Placebo Comparator | Split-face design, one application a day for 6 months |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CD0271 0.1%/CD1579 2.5% gel | Drug | one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months |
|
| Measure | Description | Time Frame |
|---|---|---|
| Description and documentation of acne lesions | over 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment effect on acne lesions | over 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Galderma Investigational site | Windsor | Ontario | Canada | |||
| Galderma Investigational site |
| ID | Term |
|---|---|
| D000152 | Acne Vulgaris |
| ID | Term |
|---|---|
| D017486 | Acneiform Eruptions |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012625 | Sebaceous Gland Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005782 | Gels |
| ID | Term |
|---|---|
| D003102 | Colloids |
| D045424 | Complex Mixtures |
| D004304 | Dosage Forms |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| CD0271 0.1%/CD1579 2.5% gel vehicle | Drug | one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months |
|
| Montreal |
| Quebec |
| Canada |
| Galderma Investigational site | Nantes | France |